Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device, $458M Deal

By: via Benzinga
In support of the company's therapy innovation strategy, Medtronic plc (NYSE: MDT) today announced that it has signed a definitive ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.